Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Agios Pharmaceuticals (AGIO) - Total assets
Total assets on the balance sheet as of December 2023 : $0.93 B
According to Agios Pharmaceuticals 's latest financial reports the company's total assets are $0.93 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Agios Pharmaceuticals - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.93 B | -24.35% |
| 2022-12-31 | $1.23 B | -13.84% |
| 2021-12-31 | $1.43 B | 68.56% |
| 2020-12-31 | $0.85 B | -4.24% |
| 2019-12-31 | $0.89 B | 3.76% |
| 2018-12-31 | $0.85 B | 39.72% |
| 2017-12-31 | $0.61 B | -0.76% |
| 2016-12-31 | $0.61 B | 47.38% |
| 2015-12-31 | $0.42 B | -14.6% |
| 2014-12-31 | $0.49 B | 144.48% |
| 2013-12-31 | $0.20 B | 46.86% |
| 2012-12-31 | $0.13 B | -29.55% |
| 2011-12-31 | $0.19 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 24,069.96% | 🇺🇸 USA |
 Eli Lilly LLY | $63.94 B | 6,723.42% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $73.94 B | 7,790.35% | 🇬🇧 UK |
 Xencor XNCR | $0.95 B | 1.66% | 🇺🇸 USA |
 Exelixis EXEL | $2.80 B | 199.19% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.87 B | 633.38% | 🇺🇸 USA |